Dr. Jyoti Wadhwa

• Solid tumour treatment and hematological malignancies
• Breast cancer
• Lung cancer
• Gastrointestinal cancers
• Head & neck cancers
• Leukemia, lymphoma
• Multiple myeloma

• Chemotherapy
• Immunotherapy
• Precision Oncology

• Vice Chairperson and Head of Department of Medical Oncology & Hematology, Paras Healthcare Pvt. Ltd. Gurugram, Haryana, India (Present)
• Senior Director, Medanta-The Medicity, Gurgaon (Apr 2022 – Apr 2023)
• Director of medical Oncology, Medanta-The Medicity, Gurgaon (Jun 2017 – Mar 2022)
• Associate Director of Medical Oncology, Medanta-The Medicity Hospital (Feb 2011 – 2017)
• Deputy Secretary, National Academy of Medical Sciences, New Delhi (Jul 2010 – Jan 2011)
• Assistant Professor of Medical Oncology, All India Institute of Medical Sciences, New Delhi (2001 – 2004)

• Cancer Care Leadership Award in Medical Oncology, Cancer Care Summit Awards (Feb 2025)
• Most Iconic Medical Oncologist of Gurgaon, Golden Aim Conference & Awards (Aug 2024)
• Precision Oncologist of The Year, Voice of Healthcare & Next Edge (Apr 2024)
• The Most Trusted Medical & Hemato Oncologist Award, Asia GCC (Aug 2023)
• Verified Certificate of Achievement for completion of the course on Nutrition & Cancer, Wageningen University and Research (Oct 2019)
• Times Healthcare Achievers Award, Delhi NCR, The Times Of India (Dec 2017)
• Certificate of Appreciation for Excellent Patient Care, Medanta – The Medicity Hospital, Gurgaon (Oct 2014)
• Sir Shriram Memorial Award, NAMS India (Nov 2008)

Memberships:

• Delhi Medical Association (DMA)
• Life Member of Indo-American Cancer Association (IACA)
• Active Member, American Society of Clinical Oncology (ASCO)
• Member, European Society of Medical Oncology (ESMO)
• Assistant Editor of the Journal of National Academy of Medical Sciences

• Rajpoot, J., Jain, M., Pujani, M., Agarwal, C., Wadhwa, R., & Sarohi, M. (2024). Pediatric hepatocellular carcinoma in a 14-year-old boy: A rare case report. Journal of Cancer Research and Therapeutics, 20(5), 1650-1653.
• Wadhwa, J., & Saigal, S. (2012). Hepatocellular Carcinoma: Challenges in Indian Scenario. Medicalization of Nervous and Emotional Problems 19, 48(1&2), 1-18.
• Wadhwa, J., Kumar, L., & Kochupillai, V. (2002). VAD followed by VMCP: An alternative regimen for multiple myeloma. Medical Oncology, 19, 105-108.
• Wadhwa, J., Asthana, A., Shilakari, G., Chopra, A. K., & Singh, R. (2015). Research Article Development and Evaluation of Nanoemulsifying Preconcentrate of Curcumin for Colon Delivery.
• Wadhwa, J., Karyampudi, A., Balaguru, S., & Hamide, A. (2014). Lymphoplasmacytic lymphoma. JIPMER Journal of Cancer, 4, 52-54.

• Authored a book titled “Diet & Cancer: Mystery, Myth and Truth”
• Authored a book titled, “Breast Cancer – Fear, Facts & Hope”

• Language Support: Cancer Rounds provides assistance in all the languages.
• Services Offered: Visa and travel assistance, pre-treatment virtual consultations, dedicated international patient support team and second opinion

“My heartfelt gratitude for the exceptional care and support during my mother’s cancer treatment. Your expertise, unwavering dedication and kindness have helped us come out of this challenging journey.” – Arijit D.“Dr. Wadhwa is a knowledgeable and caring doctor. Her expertise in oncology has helped me a lot in my cancer treatment.” – Sanjay Das“Dr. Jyoti is a best medical oncologist. I reached out to her for a second opinion, and very compassionately, she explained everything regarding the health condition and best possible treatment plan.” – Rekha“I highly recommend her for cancer treatment.” – Akash Rai

• Patient-Centered Care: Dr. Wadhwa is a highly trained medical oncologist. Her patient-centric approach and compassionate nature have helped numerous cancer patients live longer and fuller lives with improved quality of life. She ensures patients and their families feel heard, supported, and empowered throughout their challenging journey.

• Technology & Innovation: As a dedicated medical oncologist, Dr. Jyoti Wadhwa stays at the forefront of her field, integrating the latest diagnostic tools, evidence-based treatments, and cutting-edge therapies into her practice. This includes leveraging advancements in genomics, targeted therapy, and immunotherapy to develop highly personalised and effective treatment plans. Her commitment to innovation ensures patients have access to the most promising and appropriate treatment options available, aiming for optimal outcomes and minimized side effects.